UEPIX
Price
$24.19
Change
-$0.16 (-0.66%)
Updated
Jun 3 closing price
Net Assets
6.82M
VEURX
Price
$47.24
Change
-$0.60 (-1.25%)
Updated
Jun 3 closing price
Net Assets
37.8B
Interact to see
Advertisement

UEPIX vs VEURX

Header iconUEPIX vs VEURX Comparison
Open Charts UEPIX vs VEURXBanner chart's image
UEPIX vs VEURX Comparison Chart in %
View a ticker or compare two or three
VS
UEPIX vs. VEURX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is UEPIX is a Hold and VEURX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEURX has more cash in the bank: 37.8B vs. UEPIX (6.83M). VEURX pays higher dividends than UEPIX: VEURX (2.62) vs UEPIX (1.36). UEPIX was incepted earlier than VEURX: UEPIX (27 years) vs VEURX (36 years). UEPIX (2.53) is less costly to investors than VEURX (0.23). UEPIX is a more actively managed with annual turnover of: 712.00 vs. VEURX (5.00). VEURX has a lower initial minimum investment than UEPIX: VEURX (0) vs UEPIX (15000). UEPIX annual gain was more profitable for investors over the last year : 43.85 vs. VEURX (16.35). UEPIX return over 5 years is better than : 85.40 vs. VEURX (29.18).
UEPIXVEURXUEPIX / VEURX
Total Expense Ratio1.780.23774%
Annual Report Gross Expense Ratio2.530.231,100%
Fund Existence27 years36 years-
Gain YTD25.5156.638384%
Front LoadN/AN/A-
Min. Initial Investment150000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.83M37.8B0%
Annual Yield % from dividends1.362.6252%
Returns for 1 year43.8516.35268%
Returns for 3 years89.9345.72197%
Returns for 5 years85.4029.18293%
Returns for 10 years168.0983.80201%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMKBX18.05N/A
N/A
Morgan Stanley Inst Emerging Mkts A
RBCRX12.90N/A
N/A
RBC China Equity R6
DURPX29.76N/A
N/A
DFA US Hi Relatv Profitability Instl
FQTEX14.98N/A
N/A
Franklin Templeton SMACS: Series E Adv
DWOIX21.64-0.26
-1.19%
BNY Mellon Research Growth I